Clinical Trial Update: Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial [Phase 2]

View source ↗

Summary

Phase II trial of Y-3 Injection for acute ischemic stroke has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Y-3 Injection

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED